About Biotech Community Membership

SITC Biotech Membership Dues: $5,000 Annually (Jan 1 – Dec 31, 2026)

In 2023, SITC’s Board of Directors launched a six-part strategic plan to engage the entire IO biotech ecosystem with a bold goal—supporting the approval of 100 novel IO agents by 2034. With seven novel agents approved in 2024 and six novel agents with PDUFA dates in 2025, our community is well on its way to meeting this visionary goal for patients.

As our community leads the next wave of IO, the SITC Biotech Committee is honored to open the opportunity to join this incredible movement to the entire IO community. The SITC Biotech Community Membership is open to non-individuals (e.g., organizations, corporations, educational institutions) that share our vision for 100 IO novel agents. 

The SITC Biotech Community Membership program is designed to ensure the entire biotech ecosystem has access to education, networking, partnership and other growth opportunities through accessible and unique initiatives specific to the biotech community. As you’ll see from the benefits included, our goal is to ensure any entity within our vibrant IO biotech ecosystem has access to the programs developed by the Biotech Committee and shares in the recognition of our field’s success.

The dues structure for general membership is a set fee with discrete benefits for each member company, including waved registration fees to all the Biotech Committee programs in 2026.

SITC Biotech Membership Benefits 

SITC Biotech Strategic Thinktank (Summer 2026)

This unique one-day program will feature engaging panels of investors, c-suite leaders, and academic experts. The thinktank is designed to elevate the promise of IO, understand strategies to finance clinical inflection points, and build a network of professionals to support the biotech community.

Biotech Community Member companies receive one complimentary registration to the event. Logos of Biotech Members will be displayed on signage at the event in recognition of their support of SITC’s biotech initiatives.

SITC Biotech Regulatory Roundtable hosted during the SITC Annual Meeting (Nov. 2026)

The SITC Biotech Regulatory Roundtable is an opportunity for SITC to represent the unique needs of the biotech community with a unified voice to the FDA. Through moderated fireside chats with FDA leaders, attendees will have an intimate opportunity to ask questions of FDA leaders and strategize regulatory approaches with peers in biotech leadership.

Biotech Community Member companies receive two complimentary registrations to the event. Logos of Biotech Members will be displayed on signage at the event in recognition of their support of SITC’s biotech initiatives.

SITC Workshop hosted during the SITC Annual Meeting (Nov. 2026)

The 2026 New Frontiers in IO Drug Development: Novel Agents and Emerging Technologies Annual Workshop will accelerate the translation of next-generation immunotherapies into clinical impact. This highly interactive, pre-conference Annual Meeting program will convene leaders in a range of cutting edge immunotherapies and technologies, from antibody engineering, cell therapy, IO combinations, mRNA platforms, innate immunity, TME-modulating therapeutics, to AI-driven biomarker discovery.

Biotech Community Member companies receive one complimentary registration to the event.